Avivagen Inc (VIVXF)

Receives Approval for OxC-beta in Vietnam


Joe GomesMedia Inquiries
Senior Generalist Equity Analyst
February 23, 2022
Report ID: 24515
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Avivagen Inc
Avivagen Inc
Healthcare
Drug Manufacturers
Ticker
VIVXF
Current Price
$0.0017
Market Cap
$132.1K
Price Target
Refer to Report
52wk Range
$0.0004 - $0.0625
Related Research Reports
3/17/2023

Terminating Research Coverage
Terminating Research Coverage (VIVXF)
10/25/2022

Securing More Financing
Securing More Financing (VIVXF)
9/20/2022

Slower Quarter but Increasing Activity
Slower Quarter but Increasing Activity (VIVXF)
8/5/2022

AB Vista Gets on the Board
AB Vista Gets on the Board (VIVXF)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.